Disposition of 1534 shares by Nathan Lowstuter of CAMP4 THERAPEUTICS subject to Rule 16b-3
| CAMP Stock | USD 1.64 0.01 0.61% |
Slightly above 62% of CAMP4 THERAPEUTICS's investor base is looking to short. The analysis of overall sentiment of trading CAMP4 THERAPEUTICS PORATION stock suggests that many investors are alarmed at this time. CAMP4 THERAPEUTICS's investing sentiment overview a quick insight into current market opportunities from investing in CAMP4 THERAPEUTICS PORATION. Many technical investors use CAMP4 THERAPEUTICS stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Filed transaction by CAMP4 THERAPEUTICS PORATION Officer Chief Supply Chain Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
CAMP4 THERAPEUTICS Fundamental Analysis
We analyze CAMP4 THERAPEUTICS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CAMP4 THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CAMP4 THERAPEUTICS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
CAMP4 THERAPEUTICS is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
CAMP4 THERAPEUTICS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CAMP4 THERAPEUTICS stock to make a market-neutral strategy. Peer analysis of CAMP4 THERAPEUTICS could also be used in its relative valuation, which is a method of valuing CAMP4 THERAPEUTICS by comparing valuation metrics with similar companies.
Peers
CAMP4 THERAPEUTICS Related Equities
| ADTN | ADTRAN | 8.11 | ||||
| HLIT | Harmonic | 3.35 | ||||
| AIOT | PowerFleet, | 1.84 | ||||
| DGII | Digi International | 1.80 | ||||
| KVHI | KVH Industries | 1.14 | ||||
| AMBA | Ambarella | 0.42 | ||||
| CMTL | Comtech Telecommunicatio | 5.53 |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.